PwC Predicts Forces Shaping Healthcare in 2018; Some Could Impact Clinical Laboratories and Anatomic Pathology Groups
PwC’s list of 12 factors that will shape the healthcare landscape in 2018 calls attention to many new innovations Dark Daily has reported on that will impact how medical laboratories perform their tests PwC’s Health Research Institute (HRI) issued its annual report, detailing the 12 factors expected to impact the healthcare industry the most in 2018. Dark Daily culled items from the list that will most likely impact clinical laboratories and anatomic pathology groups. They include: Artificial...New FDA Regulations of Clinical Decision-Support/Digital Health Applications and Medical Software Has Consequences for Medical Laboratories
Softened FDA regulation of both clinical-decision-support and patient-decision-support software applications could present opportunities for clinical laboratory developers of such tools Late 2017, the Food and Drug Administration (FDA) released guidelines on how the agency intends to regulate—or not regulate—digital health, clinical-decision-support (CDS), and patient-decision-support (PDS) software applications. The increased/decreased oversight of the development of these physicians’ tools...Declining In-Patient Admission Rates Blamed on High-Deductible Health Plans; Could Impact Hospital-Based Medical Laboratories
Clinical laboratories may want to offset plunging patient lab specimens by increasing outreach business Hospital admissions are in decline across the country and the trend is being blamed in part on the rising use of high-deductible health plans (HDHP). The implications for hospital-based clinical laboratories is that lower in-patient totals reduce the flow of patient lab specimens as well. This situation may encourage some hospital and health-system labs to increase their lab outreach...Revenue Recovery and Collections Solutions for Your Laboratory
Your lab deserves to get paid! Learn more about this revenue recovery solution that helps you to get paid, while maintaining diplomatic relations with your patients. Explore first party, third party, and late-stage collection services providing the right solution for your lab, at the right time.
Innovative products and services in the fields of pharmaceuticals and diagnostics that make us a world leader in personalized healthcare
We are a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. With truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system—in addition to being a frontrunner in in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management—our combined strengths of pharmaceuticals and diagnostics under one roof have made us the world leader in personalized healthcare.